Skip to main content
SpringerLink
Log in

Regulation of protein kinase C and role in cancer biology

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

Protein kinase C (PKC) is a family of closely related lipid-dependent and diacyglycerol-activated isoenzymes known to play an important role in the signal transduction pathways involved in hormone release, mitogenesis and tumor promotion. Reversible activation of PKC by the second messengers diacylglycerol and calcium is an established model for the short term regulation of PKC in the immediate events of signal transduction. PKC can also be modulated long term by changes in the levels of activators or inhibitors for a prolonged period or by changes in the levels of functional PKC isoenzymes in the cell during development or in response to hormones and/or differentiation factors. Indeed, studies have indicated that the sustained activation or inhibition of PKC activityin vivo may play a critical role in regulation of long term cellular events such as proliferation, differentiation and tumorigenesis. In addition, these regulatory events are important in colon cancer, where a decrease in PKC activators and activity suggests PKC acts as an anti-oncogene, in breast cancer, where an increase in PKC activity suggests an oncogenic role for PKC, and in multidrug resistance (MDR) and metastasis where an increase in PKC activity correlates with increased resistance and metastatic potential. These studies highlight the importance and significance of regulation of PKC activityin vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Takai Y, Kishimoto A, Inoue M, Nishizuka Y: Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues: purification and characterization of an active enzyme from bovine cerebellum. J Biol Chem 252: 7603–7609, 1977

    Google Scholar 

  2. Takai Y, Kishimoto A, Iwasa Y, Kawahara Y, Mori T, Nishizuka Y: Calcium-dependent activation of a multifunctional protein kinase by membrane phospholipids. J Biol Chem 254: 3692–3695, 1979

    Google Scholar 

  3. Kishimoto A, Takai Y, Mori T, Kikkawa U, Nishizuka Y: Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover. J Biol Chem 255: 2273–2276, 1980

    Google Scholar 

  4. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y: Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257: 7847–7851, 1982

    Google Scholar 

  5. Niedel JE, Kuhn LJ, Vandenbark GR: Phorbol diester receptor copurifies with protein kinase C. Proc Natl Acad Sci USA 80: 36–40, 1983

    Google Scholar 

  6. Nishizuka Y: The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334: 661–665, 1988

    Google Scholar 

  7. House C, Kemp BE: Protein kinase contains a pseudosubstrate prototype in its regulatory domain. Science 238: 1726–1728, 1987

    Google Scholar 

  8. Kaibuchi K, Fukumoto Y, Oku N, Takai Y, Arai K, Muramatsu M: Molecular genetic analysis of the regulatory and catalytic domains of protein kinase C. J Biol Chem 264: 13489–13496, 1989

    Google Scholar 

  9. Ono Y, Fujii T, Ogita K, Kikkawa U, Igarashi K, Nishizuka Y: Protein kinase C ξ subspecies from rat brain: Its structure, expression, and properties. Proc Natl Acad Sci USA 86: 3099–3103, 1989

    Google Scholar 

  10. Quest AFG, Bardes ESG, Bell RM: A phorbol ester binding domain of protein kinase C gamma. High affinity binding to a glutathione-S- transferase/Cys 2 fusion protein. J Biol Chem 269: 2953–2960, 1994

    Google Scholar 

  11. Quest AFG, Bardes ESG, Bell RM: A phorbol ester binding domain of protein kinase C gamma. Deletion analysis of the Cys2 domain defines a minimal 43-amino acid peptide. J Biol Chem 269: 2961–2970, 1994

    Google Scholar 

  12. Parker P. Coussens L, Totty N, Rhee L, Young S, Chen E, Stabel S, Waterfield M, Ullrich A: The complete primary structure of PKC - the major phorbol ester receptor. Science 233: 853–859, 1986

    Google Scholar 

  13. Luo J-H, Weinstein IB: Calcium-dependent activation of protein kinase C. The role of the C2 domain in divalent cation selectivity. J Biol Chem 268: 23580–23584, 1993

    Google Scholar 

  14. Kishimoto A, Mikawa K, Hashimoto K, Yasudu I, Tanaka SI, Tominaga M, Kurada T, Nishizuka Y: Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (Calpain). J Biol Chem 264: 4088–4092, 1989

    Google Scholar 

  15. Stabel S, Parker PJ: Protein kinase C. Pharmacol Ther 51: 71–95, 1991

    Google Scholar 

  16. Bell RM, Burns DJ: Lipid activation of protein kinase C. J Biol Chem 266: 4661–4664, 1991

    Google Scholar 

  17. Sando JJ, Maurer MC, Bolen EJ, Grisham CM: Role of cofactors in protein kinase C activation. Cell Signal 4: 595–609, 1992

    Google Scholar 

  18. Hug H, Sarre TF: Protein kinase C isoenzymes: Divergence in signal transduction? Biochem J 291: 329–343, 1993

    Google Scholar 

  19. Hannun Y-A, Loomis CR, Bell RM: Activation of protein kinase C by triton X-100 mixed micelles containing diacylglycerol and phosphatidylserine. J Biol Chem 260: 10039–10043, 1985

    Google Scholar 

  20. Hannun YA, Loomis CR, Bell RM: Protein kinase C activation in mixed micelles: mechanistic implications of phospholipid, diacylglycerol, and calcium interdependencies. J Biol Chem 261: 7184–7190, 1986

    Google Scholar 

  21. Murakami K, Chan SY, Routtenberg A: Protein kinase C activation by cis-fatty acid in the absence of Ca2+ and phospholipid. J Biol Chem 261: 15424–15429, 1986

    Google Scholar 

  22. Sekiguchi K, Tsukuda M, Ogita K, Kikkawa U, Nishizuka Y: Three distinct forms of rat brain protein kinase C: differential response to unsaturated fatty acids. Biochem Biophys Res Commun 145: 797–802, 1987

    Google Scholar 

  23. Verkest V, McArthur M, Hamilton S: Fatty acid activation of protein kinase C: dependence on diacylglycerol. Biochem Biophys Res Commun 152: 825–829, 1988

    Google Scholar 

  24. el Touny S, Khan W, Hannun Y: Regulation of platelet protein kinase C by oleic acid. Kinetic analysis of allosteric regulation and effects on autophosphorylation, phorbol ester binding, and susceptibility to inhibition. J Biol Chem 265: 16437–16443, 1990

    Google Scholar 

  25. Khan WA, Blobe GC, Hannun YA: Activation of protein kinase C by oleic acid. Determination and analysis of inhibition by detergent micelles and physiologic membranes: Requirement for free oleate. J Biol Chem 267: 3605–3612, 1992

    Google Scholar 

  26. Berridge MJ, Irvine RF: Inositol phosphates and cell signalling. Nature 341: 197–205, 1989

    Google Scholar 

  27. Bell RM: Protein kinase C activation by diacylglycerol second messengers. Cell 45: 631–632, 1986

    Google Scholar 

  28. Hannun YA, Bell RM: Mechanism of activation of protein kinase C: role of diacylglycerols and calcium second messengers. In: Mandel LJ, Eaton DC (eds) Cell Calcium and the Control of Membrane Transport. Rockefeller University Press, New York, 1987, pp 230–240

    Google Scholar 

  29. Rozengurt E: Early signals in the mitogenic response. Science 234: 161–166, 1986

    Google Scholar 

  30. Morrison DK, Kaplan DR, Rhee SG, Williams LT: Platelet derived growth factor (PDGF)-dependent association of phospholipase C-gamma with the PDGF receptor signalling complex. Mol Cell Biol 10: 2359–2366, 1990

    Google Scholar 

  31. Williams LT: Signal transduction by the platelet-derived growth factor receptor. Science 243: 1564–1570, 1989

    Google Scholar 

  32. Fantl WJ, Johnson DE, Williams LT: Signalling by receptor tyrosine kinases. Annu Rev Biochem 62: 453–481, 1993

    Google Scholar 

  33. Schlessinger J: Allosteric regulation of the epidermal growth factor receptor kinase. J Cell Biol 103: 2067–2072, 1986

    Google Scholar 

  34. Davis RJ: Independent mechanisms account for the regulation by protein kinase C of the epidermal growth factor receptor affinity and tyrosine-protein kinase activity. J Biol Chem 263: 9462–9469, 1988

    Google Scholar 

  35. Egan SE. Weinberg RA: The pathway to signal achievement. Nature 365: 781–783, 1993

    Google Scholar 

  36. Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, Finkenzeller G, Marmé D, Rapp UR: Protein kinase Cα activates RAF-1 by direct phosphorylation. Nature 364: 249–252, 1993

    Google Scholar 

  37. Kyiakis JM, App H, Zhang X-F, Banerjee P, Brautigan DL, Rapp UR, Avruch J: Raf-1 activates MAP kinase-kinase. Nature 358: 417–421, 1992

    Google Scholar 

  38. Smith JB, Smith L, Pettit GR: Bryostatin: Potent, new mitogens that mimic phorbol ester tumor promoters. Biochem Biophys Res Commun 132: 939–945, 1985

    Google Scholar 

  39. Blumberg PM: Protein kinase C as the receptor for the phorbol ester tumor promoters: Sixth Rhoads Memorial Award Lecture. Cancer Research 48: 1–8, 1988

    Google Scholar 

  40. Martelly I, Castagna M: Protein kinase C and tumor promoters. Curr Opin Cell Biol 1: 206–210, 1989

    Google Scholar 

  41. Fournier A, Murray AW: Application of phorbol ester to mouse skin causes a rapid and sustained loss of protein kinase C. Nature 330: 767–769, 1987

    Google Scholar 

  42. Fuchs E: Epidermal differentiation: The bare essentials. J Cell Biol. 111: 2807–2814, 1990

    Google Scholar 

  43. Dlugosz AA, Yuspa SH: Coordinate changes in gene expression which mark the spinous to granular cell transition in epidermis are regulated by protein kinase C. J Cell Biol 120: 217–225, 1993

    Google Scholar 

  44. Osada S-I, Hashimoto Y, Nomura S, Kohno Y, Chida K, Tajima O, Kubo K, Akimoto K, Koizumi H, Kitamura Y, Suzuki K, Ohno S, Kuroki T: Predominate expression of nPKCπ, a Ca2+-independent isoform of protein kinase C in epithelial tissues, in association with epithelial differentiation. Cell Growth and Differentiation 4: 167–175, 1993

    Google Scholar 

  45. Greif H, Ben-Chaim J, Shimon T, Bechor E, Eldar H, Livneh E: The protein kinase C-related PKC-L(eta) gene product is localized in the cell nucleus. Mol Cell Biol 12: 1304–1311, 1992

    Google Scholar 

  46. Dlugosz AA, Mischak H, Mushinski JF, Yuspa SH: Transcripts encoding protein kinase C-α, -δ, ε, -ξ, and -π are expressed in basal and differentiating mouse keratinocytesin vitro and exhibit quantitative changes in neoplastic cells. Mol Carcinog 5: 286–292, 1992

    Google Scholar 

  47. Gherzi R, Sparatore B, Patrone M, Sciutto A, Briata P: Protein kinase C mRNA levels and activity in reconstituted normal human epidermis: Relationships to cell differentiation. Biochem Biophys Res Commun 184: 283–291, 1992

    Google Scholar 

  48. Brooks G, Wilson RE, Dooley T, Goss MW, Hart IR: Protein kinase C down-regulation, and not transient activation, correlates with melanocyte growth. Cancer Research 51: 3281–3288, 1991

    Google Scholar 

  49. Brooks G, Goss MW, East JA, Hart IR: Growth of melanocytic cells is associated with down-regulation of protein kinase C α, δ, and [SS]! isoforms. Possible role of diacylglycerol. J Biol Chem 268: 23868–23875, 1993

    Google Scholar 

  50. Housey GM, Johnson MD, Hsiao WLW, O'Brian CA, Murphy JP, Kirchmeier P, Weinstein IB: Overproduction of protein kinase C causes disordered growth control in rat fibroblasts. Cell 52: 343–354, 1988

    Google Scholar 

  51. Persons DA, Wilkison WO, Bell RM, Finn OJ: Altered growth regulation and enhanced tumorigenicity of NIH 3T3 fibroblasts transfected with protein kinase C-1 cDNA. Cell 52: 447–458, 1988

    Google Scholar 

  52. Megidish T, Mazurek N: A mutant protein kinase C that can transform fibroblasts. Nature 342: 807–811, 1989

    Google Scholar 

  53. Borner C, Filipuzzi I, Weinstein IB, Imber R: Failure of wild-type or a mutant form of protein kinase C-α to transform fibroblasts. Nature 353: 78–80, 1991

    Google Scholar 

  54. Choi PM, Tchou-Wong K-M, Weinstein IB: Overexpression of protein kinase C in HT29 colon cancer cells causes growth inhibition and tumor suppression. Mol Cell Biol 10: 4650–4657, 1990

    Google Scholar 

  55. Mischak H,Goodnight J, Kolch W, Martiny-Baron G, Schaechtle C, Kazanietz MG, Blumberg PM, Pierce JH, Mushinski JF: Overexpression of protein kinase C-δ and-[SS]! in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J Biol Chem 268: 609–6096, 1993

    Google Scholar 

  56. Cacace AM, Nichols Guadagno S, Kruass RS, Fabbro D, Weinstein IB: The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene 8: 2095–2104, 1993

    Google Scholar 

  57. Ase K, Saito N, Shearman MS, Kikkawa U, Ono Y, Igarashi K, Tanaka C, Nishizuka Y: Distinct cerebellar expression of βI and βII subspecies of protein kinase C in rat cerebellum. J Neurosci 8: 3850–3856, 1988

    Google Scholar 

  58. Yoshida Y, Huang FL, Nakabayshi H, Huang KP: Tissue distribution and developmental expression of protein kinase C isozymes. J Biol Chem 263: 9868–9873, 1988

    Google Scholar 

  59. McConkey DJ, Jondal M, Orrenius S: Cellular signaling in thymocyte apoptosis. Seminars in Immunology 4: 371–377, 1992

    Google Scholar 

  60. Collins SJ: The HL-60 promyelocytic leukemia cell iine: proliferation, differentiation, and cellular oncogene expression. Blood 70: 1233–1244, 1987

    Google Scholar 

  61. Merrill AH Jr, Serenit A, Stevens VL, Hannun YA, Bell RM, Kinkade JM Jr: Inhibition of phorbol ester-dependent differentiation of HL-60 cells by sphinganine and other long chain bases. J Biol Chem 261: 12610–12615, 1986

    Google Scholar 

  62. Ebeling JG, Vandenbark GR, Kuhn LJ, Ganong BR, Bell RM, Niedel JE: Diacylglycerols mimic phorbol diester induction of leukemic cell differentiation. Proc Natl Acad Sci USA 82: 815–819, 1985

    Google Scholar 

  63. Martell RE, Simpson RU, Taylor JM: 1.25-Dihydroxyvitamin D3 regulation of phorbol ester receptors in HL-60 leukemia cells. J Biol Chem 262: 5570–5575, 1987

    Google Scholar 

  64. Obeid LM, Okazaki T, Karolak LA, Hannun YA: Transcriptional regulation of protein kinase C by 1,25-dihydroxyvitamin D3 in HL-60 cells. J Biol Chem 265: 2370–2374, 1990

    Google Scholar 

  65. Gamard CJ, Blobe GC, Hannun YA, Obeid LM: Specific role for protein kinase C β in cell differentiation. Cell Growth and Differentiation 6: 1994, in press

  66. Fleischman LF, Chahwala SB, Cantley L:Ras-transformed cells: altered levels of phosphatidylinositol-4,5-bisphosphate and catabolites. Science 231: 407–410, 1986

    Google Scholar 

  67. Asaoka Y, Nakamura S, Yoshida K, Nishizuka Y: Protein kinase C, calcium and phospholipid degradation. Trends Biochem Sci 17: 414–417, 1992

    Google Scholar 

  68. Aitken A, Collinge DB, van Heusden BP, Isobe T, Roseboom PH, Rosenfeld G, Soll J: 14-3-3 proteins: a highly conserved, widespread family of eukaryotic proteins. Trends Biochem Sci 17: 498–501, 1992

    Google Scholar 

  69. Toker A, Sellers LA, Amess B, Patel Y, Harris A, Aitken A: Multiple isoforms of a protein kinase C inhibitor (KCIP-1/14-3-3) from sheep brain - Amino acid sequence of phosphorylated forms. Eur J Biochem 206: 453–461, 1992

    Google Scholar 

  70. Steele G, Tepper J, Motwani J, Bruckner HW: Adenocarcinoma of the colon and rectum. In: Holland JF, Frei E, Bast RC, Kufe DW, Morton DL, Weichselbaum RR (eds) Cancer Medicine. Lea & Febiger, Malvern, PA, 1993, pp 1493–1522

    Google Scholar 

  71. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomaki P, Sistonen P, Vogelstein B: Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75: 1215–1225, 1993

    Google Scholar 

  72. Parsons R, Li G-M, Longley MJ, Fang W-H, Papadopoulos N, Jen J, de las Chapelle A, Kinzler KW, Vogelstein B, Modrich P: Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 75: 1227–1236, 1993

    Google Scholar 

  73. Weinstein IB: Nonmutagenic mechanisms in carcinogenesis: Role of protein kinase C in signal transduction and growth control. Environmental Health Perspectives 93: 175–179, 1991

    Google Scholar 

  74. Craven PA, Pfanstiel J, DeRubertis FR: Role of activation of protein kinase C in the stimulation of colonic epithelial proliferation and reactive oxygen formation by bile acids. J Clin Invest 79: 532–541, 1987

    Google Scholar 

  75. Fitzer CJ, O'Brian CA, Guillem JG, Weinstein IB: The regulation of protein kinase C by chenodeoxycholate, deoxycholate and several structurally related bile acids. Carcinogenesis 8: 217–220, 1987

    Google Scholar 

  76. Guillem JG, O'Brian CA, Fitzer CJ, Forde KA, LoGerfo P, Treat M, Weinstein IB: Altered levels of protein kinase C and Ca2+-dependent protein kinases in human colon carcinomas. Cancer Research 47: 2036–2039, 1987

    Google Scholar 

  77. Phan, S-C, Morotomi M, Guillem JG, LoGerfo P, Weinstein IB: Decreased levels of 1,2-sn-diacylglycerol in human colon tumors. Cancer Res 51: 1571–1573, 1991

    Google Scholar 

  78. Levy MF, Pocsidio J, Guillem JG, Forde K, LoGerfo P, Weinstein IB: Decreased levels of protein kinase C enzyme activity and protein kinase C mRNA in primary colon tumors. Dis Colon Rectum 36: 913–921, 1993

    Google Scholar 

  79. Fisher B, Osborne CK, Margolese R, Bloomer W: Neoplasms of the breast. In: Holland JF, Frei E, Bast RC, Kufe DW, Morton DL, Weichselbaum RR (eds) Cancer Medicine. Lea & Febiger, Malvern, PA, 1993, pp 1706–1774

    Google Scholar 

  80. O'Brian CA, Vogel VG, Singletary SE, Ward NE: Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue. Cancer Res 49: 3215–3217, 1989

    Google Scholar 

  81. Borner C, Wyss R, Regazzi R, Eppenberger U, Fabbro D: Immunological quantitation of phospholipid/Ca2+-dependent protein kinase of human mammary carcinoma cells: Inverse relationship to estrogen receptors. Int J Cancer 40: 344–348, 1987

    Google Scholar 

  82. Wiebe VJ, Osborne CK, Fuqua SAW, DeGregorio MW: Tamoxifen resistance in breast cancer. Crit Rev Oncol Hematol 14: 173–188, 1993

    Google Scholar 

  83. Fabbro D, Regazzi R, Costa SD, Borner C, Eppenberger U: Protein kinase C desensitization by phorbol esters and its impact on growth of human breast cancer cells. Biochem Biophys Res Commun 135: 65–73, 1986

    Google Scholar 

  84. Darbon J-M, Valette A, Bayard F: Phorbol esters inhibit the proliferation of MCF-7 cells: possible implication of protein kinase C. Biochem Pharmacol 35: 2683–2686, 1986

    Google Scholar 

  85. O'Brian CA, Liskamp RM, Solomon DH, Weinstein IB: Inhibition of protein kinase C by tamoxifen. Cancer Res 45: 2462–2465, 1985

    Google Scholar 

  86. Issandou M, Bayard F, Darbon J-M: Inhibition of MCF-7 cell growth by 12-O-tetradecanoylphorbol-13-acetate and 1,2-dioctanoyl-sn-glycerol: Distinct effects of protein kinase C activity. Cancer Research 48: 6943–6950, 1988

    Google Scholar 

  87. Moscow J, Cowan K: Multidrug resistance. JNCI 80: 14–19, 1988

    Google Scholar 

  88. Endicott JA, Ling V: The biochemistry of P-glycoprotein mediated MDR. Annu Rev Biochem 58: 137–171, 1989

    Google Scholar 

  89. O'Brian C, Ward N: Biology of the PKC family. Cancer and Metastasis Review 8: 199–214, 1989

    Google Scholar 

  90. Kartner N, Riordan JR, Ling V: Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 221: 1285–1287, 1983

    Google Scholar 

  91. Gros P, Croop J, Housman D: Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47: 371–380, 1986

    Google Scholar 

  92. Nooter K, Herweijer H: Multidrug resistance (mdr) genes in human cancer. Br J Cancer 63: 663–669, 1991

    Google Scholar 

  93. Safa AR, Glover CJ, Meyers MB, Biedler JL, Felsted RL: Vincristine photoaffinity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug-resistant cells. J Biol Chem 261: 6137–6140, 1986

    Google Scholar 

  94. Hamada H, Tsuruo T: Purification of the 170- to 180-Kilodalton membrane glycoprotein associated with multidrug resistance. J Biol Chem 263: 1454–1458, 1988

    Google Scholar 

  95. Ueda K, Cardarelli C, Gottesman M, Pastan I: Expression of full length cDNA for the human ‘MDR1’ gene confers resistance to colchicine, doxorubicin and vinblastine. Proc Natl Acad Sci USA 84: 3004–3008, 1987

    Google Scholar 

  96. Tsurou T, Iida H, Kawabata H, Tsukagoshi S, Sakurai Y: High calcium content of pleitropic drug-resistant P388 and K562 leukemia and Chinese hamster ovary cells. Cancer Research 44: 5095–5099, 1984

    Google Scholar 

  97. Fine R, Patel J, Chabner B: Phorbol esters induce MDR in human breast cancer cells. Proc Natl Acad Sci USA 85: 582–586, 1988

    Google Scholar 

  98. Aquino A, Hartman KD, Knode MC, Grant S, Huang KP, Niu CH, Glazer RI: Role of protein kinase C in phosphorylation of vinculin in adriamycin-resistant HL-60 leukemia cells. Cancer Research 48: 3324–3329, 1988

    Google Scholar 

  99. O'Brian CA, Fan D, Ward NE, Seid C, Fidler IJ: Level of protein kinase C activity correlates directly with resistance to adriamycin in murine fibrosarcoma cells. FEBS Lett 246: 78–82, 1989

    Google Scholar 

  100. Ido M, Sato K, Sakurai M, Inagaki M, Saitoh M, Watanabe M, Hidaka H: Decreased phorbol ester receptor and protein kinase C in P388 murine leukemia cells resistant to etoposide. Cancer Research 47: 3460–3463, 1987

    Google Scholar 

  101. Schwartz G, Arkin H, Holland J, Ohnuma T: PKC activity and MDR in MOLT-3 human lymphoblastic leukemia cells resistant to trimetrexate. Cancer Research 51: 55–61, 1991

    Google Scholar 

  102. O'Brian C, Fan D, Ward N, Dong Z, Iwamoto L,Gupta K, Earnsest L, Fidler I: Transient enhancement of MDR by the bile acid deozycholate in murine fibrosarcoma cellsin vitro. Biochemical Pharmacology 41: 797–806, 1991

    Google Scholar 

  103. Dong Z, Ward N, Fan D, Gupta K, O'Brian C:In vitro model for intrinsic drug resistance: effects of PKC activators on the chemosensitivity of cultured human colon cancer cells. Molecular Pharmacology 39: 563–569, 1991

    Google Scholar 

  104. Posada J, McKeegan E, Worthington K, Morin M, Jaken S, Tritton T: Human multidrug resistant KB cells overexpress PKC: Involvement in drug resistance. Cancer Communications 1: 285–292, 1989

    Google Scholar 

  105. Ido M, Sakurai M, Inagaki M, Saito M, Hidaka H: An inhibitor of protein kinase C 1-(5-isoquinolinylsulfonyl)-2-methypiperazine(H-7) inhibits TPA-induced reduction of vincristine uptake from P388 murine leukemia cell. Leuk Res 10: 1063–1069, 1986

    Google Scholar 

  106. Chambers TC, Zheng B, Kuo JF: Regulation by phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells. Mol Pharmacol 41: 1008–1015, 1992

    Google Scholar 

  107. Mori T, Takai Y, Minakuchi R, Yu B, Nishizuka Y: Inhibitory action of chlorpromazine, dibucaine, and other phospholipid-interacting drugs on calcium-activated, phospholipid-dependent protein kinase. J Biol Chem 255: 8378–8380, 1980

    Google Scholar 

  108. O'Brian CA, Ward NE, Liskamp RM, De Bont DB, Earnest LE, Van Boom JH, Fan D: A novel N-myristylated synthetic octapeptide inhibits protein kinase C activity and partially reverses murine fibrosarcoma cell resistance to Adriamycin. Invest New Drugs 9: 169–179, 1991

    Google Scholar 

  109. Chambers T, McAvoy E, Jacobs J, Eilon G: PKC phosphorylates P-glycoprotein in MDR human KB carcinoma cells. J Biol Chem 265: 7679–7686, 1990

    Google Scholar 

  110. Yu G, Ahmad S, Aquino A, Fairchild CR, Trepel JB, Ohno S, Suzuki K, Tsurou T, Cowan KH, Glazer RI: Transfection with protein kinase Cα confers increased multidrug resistance to MCF-7 cells overexpressing P-glycoprotein. Cancer Communications 3: 181–189, 1991

    Google Scholar 

  111. Ahmad S, Trepel JB, Ohno S, Suzuki K, Tsuruo T, Glazer RI: Role of protein kinase C in the modulation of multidrug resistance: Expression of the atypical gamma isoform of protein kinase C does not confer increased resistance to doxorubicin. Mol Pharmacol 42: 1004–1009, 1992

    Google Scholar 

  112. Fan D, Fidler IJ, Ward NE, Seid C, Earnest LE, Housey GM, O'Brian CA: Stable expression of a cDNA encoding rat brain protein kinase C-βI confers a multidrug-resistant phenotype on rat fibroblasts. Anticancer Res 12: 661–668, 1992

    Google Scholar 

  113. Ahmad S, Glazer RI: Expression of the antisense cDNA for protein kinase Cα attenuates resistance in doxorubicinresistant MCF-7 breast carcinoma cells. Mol PHarmacol 43: 858–862, 1993

    Google Scholar 

  114. Sahyoun N, Wolf M, Besterman J, Hsieh TS, Sander M, LeVine H, Chang KW, Cuatrecasas P: Protein kinase C phosphorylates topoisomerase II; Topoisomerase activation and its possible role in phorbol ester-induced differentiation of HL-60 cells. Proc Natl Acad Sci USA 83: 1603–1607, 1986

    Google Scholar 

  115. Taniguchi H, Pyerin W: Glutathione S-transferase is anin vitro substrate of Ca++-phospholipid-dependent protein kinase (protein kinase C). Biochem Biophys Res Commun 162: 903–907, 1989

    Google Scholar 

  116. Blobe GC, Sachs CW, Khan WA, Fabbro D, Stabel S, Wetsel WC, Obeid LM, Fine RL, Hannun YA: Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. Functional significance of enhanced expression of PKC α. J Biol Chem 268: 658–664, 1993

    Google Scholar 

  117. Ae Lee S, Karaszkiewicz JW, Anderson WB: Elevated level of nuclear protein kinase C in multidrug-resistant MCF-7 human breast carcinoma cells. Cancer Res 52: 3750–3759, 1992

    Google Scholar 

  118. Aquino A, Warren BS, Omichinski J, Hartman KD, Glazer RI: Protein kinase C-gamma is present in adriamycin resistant HL-60 leukemia cells. Biochem Biophys Res Commun 166: 723–728, 1990

    Google Scholar 

  119. Gollapudi S, Patel K, Jain V, Gupta S: Protein kinase C isoforms in multidrug resistant P388/ADR cells: A possible role in daunorubicin transport. Cancer Lett 62: 69–75, 1992

    Google Scholar 

  120. Palayoor ST, Stein JM, Hait WN: Inhibition of protein kinase C by antineoplastic agents: Implications for drug resistance. Biochem Biophys Res Commun 148: 718–725, 1987

    Google Scholar 

  121. Ward NE, O'Brian CA: Distinct patterns of phorbol esterinduced downregulation of protein kinase C activity in adriamycin-selected multidrug resistant and parental murine fibrosarcoma cells. Cancer Lett 58: 189–193, 1991

    Google Scholar 

  122. Kessel D: Effects of phorbol esters on doxorubicin transport systems. Biochem Pharmacol 37: 2297–2298, 1988

    Google Scholar 

  123. Hamada H, Hagiwara K-I, Nakajima T, Tsuruo T: Phosphorylation of the Mr 170,000 to 180,000 glycoprotein specific to MDR tumor cells: Effects of verapamil, trifluoperazine and phorbol esters. Cancer Research 47: 2860–2865, 1987

    Google Scholar 

  124. Carlsen SA, Till JE, Ling V: Modulation of drug permeability in Chinese hamster ovary cells: Possible role for phosphorylation of surface glycoproteins. Biochim Biophys Acta 467: 238–250, 1977

    Google Scholar 

  125. Mellado W, Horwitz SB: Phosphorylation of the multidrug resistant associated glycoprotein. Biochemistry 26: 6900–6904, 1987

    Google Scholar 

  126. Ma L, Marquardt D, Takemoto L, Center MS: Analysis of P-glycoprotein phosphorylation in HL60 cells isolated for resistance to vincristine. J Biol Chem 266: 5593–5599, 1991

    Google Scholar 

  127. Fidler IJ: Cancer metastasis. British Medical Bulletin 47: 157–177, 1991

    Google Scholar 

  128. Herbert J-M: Protein kinase C: A key factor in the regulation of tumor cell adhesion to the endothelium. Biochem Pharmacol 45: 527–537, 1993

    Google Scholar 

  129. Takenaga K, Takahashi K: Effects of 12-O-tetradecanoyl-phorbol-13-acetate on adhesiveness and lung-colonizing ability of Lewis lung carcinoma cells. Cancer Research 46: 375–380, 1986

    Google Scholar 

  130. Gopalakrishna R, Barsky SH: Tumor promoter-induced membrane-bound protein kinase C regulates hematogenous metastasis. Proc Natl Acad Sci USA 85: 612–616, 1988

    Google Scholar 

  131. Korczak B, Whale C, Kerbel RS: Possible involvement of Ca2+ mobilization and protein kinase C activation in the induction of spontaneous metastasis by mouse mammary adenocarcinoma cells. Cancer Res 49: 2597–2602, 1989

    Google Scholar 

  132. Schwartz GK, Redwood SM, Ohnuma T, Holland JF, Droller MJ, Liu BCS: Inhibition of invasion of invasive human bladder carcinoma cells by protein kinase C inhibitor staurosporine. JNCI 82: 1753–1756, 1990

    Google Scholar 

  133. Dumont JA, JOnes WD, Bitonti AJ: Inhibition of experimental metastasis and cell adhesion of B16F1 melanoma cells by inhibitors of protein kinase C. Cancer Research 52: 1195–1200, 1992

    Google Scholar 

  134. Lane TA, Lamkin GE, Wancewicz E: Modulation of endothelial cell expression of intracellular adhesion molecule 1 by protein kinase C activation. Biochem Biophys Res Commun 161: 945–952, 1989

    Google Scholar 

  135. Herbert J-M, Maffrand J-P: Tumor cell adherence to cultured capillary endothelial cells is promoted by activators of protein kinase C. Biochem Pharmacol 42: 163–170, 1991

    Google Scholar 

  136. Liu B, Timar J, Howlett J, Diglio CA, Honn KV: Lipoxygenase metabolites of arachadonic and linoleic acids modulate the adhesion of tumor cells to endothelium via regulation of protein kinase C. Cell Regul 2: 1045–1055, 1991

    Google Scholar 

  137. Ono Y, Fujii T, Ogita K, Kikkawa U, Igarashi K, Nishizuka Y: The structure, expression, and properties of additional members of the protein kinase C family. J Biol Chem 263: 6927–6932, 1988

    Google Scholar 

  138. Ohno S, Kawasaki H, Imajoh S, Suzuki K: Tissue-specific expression of three distinct types of rabbit protein kinase C. Nature 325: 161–166, 1987

    Google Scholar 

  139. Knopf J, Lee M-H, Sultzman LA, Kritz RW, Loomis CR, Hewick RM, Bell RM: Cloning and expression of multiple protein kinase C cDNAs. Cell 46: 491–502, 1986

    Google Scholar 

  140. Kosaka Y, Ogita K, Ase K, Nomura H, Kikkawa U, Nishizuka Y: The heterogeneity of protein kinase C in various rat tissues. Biochem Biophys Res Commun 151: 973–981, 1988

    Google Scholar 

  141. Brandt S, NIedel J, Bell RM, Young WS: Distinct patterns of expression of different PKC mRNAs in rat tissues. Cell 49: 57–63, 1987

    Google Scholar 

  142. Wada H, Ohno S, Suzuki K: Cell-type specific expression of the genes for the PKC family: Down regulation of the mRNAs for PKC α and nPKCε uponin vitro differentiation of a mouse neuroblastoma cell line neuro 2a. Biochem Biophys Res Commun 165: 533–538, 1989

    Google Scholar 

  143. Wetsel WC, Khan WA, Merchenthaler I, Rivera H, Halpern AE, Phung HM, Negro-Vilar A, Hannun YA: Tissue and cellular distribution of the extended family of protein kinase C isoenzymes. J Cell Biol 117: 121–133, 1992

    Google Scholar 

  144. Mischak H, Kolch W, Goodnight J, Davidson WF, Rapp U, Rose-John S, Mushinski JF: Expression of protein kinase C genes in hemopoietic cells is cell-type- and B cell-differentiation stage specific. J Immunol 147: 3981–3987, 1991

    Google Scholar 

  145. Borner C, Guadagno SNBioh, Fabbro D, Weinstein IB: Expression of four protein kinase C isoforms in rat fibroblasts. Distinct subcellular distribution and regulation by calcium and phorbol esters. J Biol Chem 267: 12892–12899, 1992

    Google Scholar 

  146. Gschwendt M, Leibersperger H, Kittstein W, Marks F: Protein kinase Czeta and eta in murine epidermis: TPA induces down-regulation of PKCeta but not PKCzeta. FEBS Lett 307: 151–155, 1992

    Google Scholar 

  147. Khalil RA, Lajoie C, Resnick MS, Morgan KG: Ca2+-independent isoforms of protein kinase C differentially translocate in smooth muscle. Am J Physiol Cell Physiol 263: C714-C718, 1992

    Google Scholar 

  148. Kohout TA, Rogers TB: Use of a PCR-based method to characterize protein kinase C isoform expression in cardiac cells. Am J Physiol Cell Physiol 264: C1350-C1359, 1993

    Google Scholar 

  149. Huwiler A, Jung HH, Pfeilschifter J, Remé CE: Protein kinase C in the rat retina: Immunocharacterization of calcium-independent δ, [SS]! and zeta isoenzymes. Mol Brain Res 16: 360–364, 1992

    Google Scholar 

  150. Khan WA, Blobe G, Halpern A, Taylor W, Wetsel WC, Burns D, Loomis C, Hannun YA: Selective regulation of protein kinase C isoenzymes by oleic acid in human platelets. J Biol Chem 268: 5063–5068, 1993

    Google Scholar 

  151. Bacher N, Zisman Y, Berent E, Livneh E: Isolation and characterization of PKC-L, a new member of the protein kinase C-related gene family specifically expressed in lung, skin, and heart. Mol Cell Biol 11: 126–133, 1991

    Google Scholar 

  152. Osada S, Mizuno K, Saido TC, Akita Y, Suzuki K, Kuroki T, Ohno S: A phorbol ester receptor/protein kinase, nPKCeta, a new member of the protein kinase C family predominantly expressed in lung and skin. J Biol Chem 265: 22434–22440, 1990

    Google Scholar 

  153. Chang JD, Xu Y, Raychowdhury MK, Ware JA: Molecular cloning and expression of a cDNA encoding a novel isoenzyme of protein kinase C (nPKC). A new member of the nPKC family expressed in skeletal muscle, megakaryoblastic cells, and paltelets. J Biol Chem 268: 14208–14214, 1993

    Google Scholar 

  154. Sposi NM, Bottero L, Cossu G, Russo G, Testa U, Peschle C: Expression of protein kinase C genes during ontogenic development of the central nervous system. Mol Cell Biol 9: 2284–2288, 1989

    Google Scholar 

  155. Huang FL, Young WS III, Yoshida Y, Huang K-P: Developmental expression of protein kinase C isozymes in rat cerebellum. Dev Brain Res 52: 121–130, 1990

    Google Scholar 

  156. Kim H-M, Hirota S, Onoue H, Hirata T, Suzuki K, Ohno S, Kuroki T, Kitamura Y, Nomura S: Localization and development expression of a novel protein kinase Cδ gene. Dev Brain Res 70: 239–244, 1992

    Google Scholar 

  157. Borner C, Guadagno SN, Hsieh L-L, Hsiao W, Weinstein IB: Transformation by aras oncogene causes increased expression of protein kinase C-α and decreased expression of protein kinase C-ε. Cell Growth and Differentiation 1: 653–660, 1990

    Google Scholar 

  158. Borner C, Guadagno SN, Hsiao WW-L, Fabbro D, Barr M, Weinstein IB: Expression of four protein kinase C isoforms in rat fibroblasts. Differential alterations inras-,src-, andfos-transformed cells. J Biol Chem 267: 12900–12910, 1992

    Google Scholar 

  159. Alcantara O, Javors M, Boldt DH: Induction of protein kinase C mRNA in cultured lymphoblastoid T cells by irontransferrin but not by soluble iron. Blood 77: 1290–1297, 1991

    Google Scholar 

  160. McSwine-Kennick RL, McKeegan EM, Johnson MD, Morin MJ: Phorbol diester-induced alterations in the expression of protein kinase C isozymes and their mRNAs. Analysis in wild-type and phorbol diester-resistant HL-60 cell clones. J Biol Chem 266: 15135–15143, 1991

    Google Scholar 

  161. Gruber JR, Ohno S, NIles RM: Increased expression of protein kinase Cα plays a key role in retinoic acid-induced melanoma differentiation. J Biol Chem 267: 13356–13360, 1992

    Google Scholar 

  162. Rosenbaum SE, NIles RM: Regulation of protein kinase C gene expression by retinoic acid in B16 mouse melanoma cells. Arch Biochem Biophys 294: 123–129, 1992

    Google Scholar 

  163. Blobe GC, Khan WA, Halpern AE, Obeid LM, Hannun YA: Selective regulation of expression of protein kinase C β isoenzymes occurs via alternative splicing. J Biol Chem 268: 10627–10635, 1993

    Google Scholar 

  164. Ponzoni M, Lucarelli E, Corrias MV, Cornaglia-Ferraris P: Protein kinase C isoenzymes in human neuroblasts: Involvement of PKC ε in cell differentiation. FEBS Lett 322: 120–124, 1993

    Google Scholar 

  165. Tonetti DA, Horio M, Collart FR, Huberman E: Protein kinase C β gene expression is associated with susceptibility of human promyelocytic leukemia cells to phorbol esterinduced differentiation. Cell Growth and Differentiation 3: 739–745, 1992

    Google Scholar 

  166. Freire-Moar J, Cherwinski H, Hwang F, Ransom J, Webb D: Expression of protein kinase C isoenzymes in thymocyte subpopulations and their differential regulation. J Immunol 147: 405–409, 1991

    Google Scholar 

  167. Brick-Ghannam C, Huang FL, Temime N, Charron D: Protein kinase C (PKC) activation via human leukocyte antigen class II molecules. J Biol Chem 266: 24169, 24175, 1991

    Google Scholar 

  168. Otte AP, Moon RT: Protein kinase C isozymes have distinct roles in neural induction and competence in xenopus. Cell 68: 1021–1029, 1992

    Google Scholar 

  169. Reyland ME, Prack MM, Williams DL: Elevated levels of protein kinase C in Y1 cells which express apolipoprotein E decrease basal steroidogenesis by inhibiting expression of P450-cholesterol side chain cleavage mRNA. J Biol Chem 267: 17933–17938, 1992

    Google Scholar 

  170. Wang C, Constantinescu SN, MacEwan DJ, Strulovici B, Dekker LV, Parker PJ, Pfeffer LM: Interferon α induces protein kinase C-[SS]! (PKC-[SS]!) gene expression and a 4.7-kb PKC-[SS]!-related transcript. Proc Natl Acad Sci USA 90: 6944–6948, 1993

    Google Scholar 

  171. Park H-Y, Russakovsky V, Ohno S, Gilchrest BA: The β isoform of protein kinase C stimulates human melanogenesis by activating tyrosinase in pigment cells. J Biol Chem 268: 11742–11749, 1993

    Google Scholar 

  172. Hass R, Hiranom M, Kharbanda S, Rubin E, Meinhardt G, Kufe D: Resistance to phorbol ester-induced differentiation of U-937 myeloid leukemia cell variant with a signaling defect upstream to Raf-1 kinase. Cell growth and differentiation 4: 657–663, 1993

    Google Scholar 

  173. Barr LF, Mabry M, Nelkin BD, Tyler G, May WS, Baylin SB:c-myc Gene-induced alterations in protein kinase C expression: A possible mechanism facilitatingmyc-ras gene complementation. Cancer Research 51: 5514–5515, 1991

    Google Scholar 

  174. Huwiler A, Fabbro D, Pfeilschifter J: Differential recovery of protein kinase C-α and -ε isozymes after long term phorbol ester treatment in rat renal mesangial cells. Biochem Biophys Res Commun 180: 1422–1428, 1991

    Google Scholar 

  175. Krug E, Biemann H-P, Tashjian AH: Evidence for increased synthesis as well as increased degradation of protein kinase C after treatment of human osteosarcoma cells with phorbol ester. J Biol Chem 262: 11852–11856, 1987

    Google Scholar 

  176. Borner C, Filipuzzi I, Wartmann M, Eppenberger U, Fabbro D: Biosynthesis and posttranslational modifications of protein kinase C in human breast cancer cells. J Biol Chem 264: 13902–13909, 1989

    Google Scholar 

  177. Isakov N, McMahon P, Altman A: Selective post-transcriptional down-regulation of protein kinase C isoenzymes in leukemic T cells chronically treated with phorbol ester. J Biol Chem 265: 2091–2097, 1990

    Google Scholar 

  178. Makowske M, ballester R, Cayre Y, Rosen OM: Immunochemical evidence that three protein kinase C isozymes increase in abundance during HL-60 differentiation induced by dimethyl sulfoxide and retinoic acid. J Biol Chem 263: 3402–3410, 1988

    Google Scholar 

  179. Messing RO, Petersen PJ, Henrich CJ: Chronic ethanol exposure increases levels of protein kinase C δand [SS]! and protein kinase C-mediated phosphorylation in cultured neural cells. J Biol Chem 266: 23428–23432, 1991

    Google Scholar 

  180. Clark EA, Lee VM-Y: The differential role of protein kinase C isozymes in the rapid induction of neurofilament phosphorylation by nerve growth factor and phorbol esters in PC12 cells. J Neurochem 57: 802–810, 1991

    Google Scholar 

  181. Wooten MW, Seibenhener ML, Soh Y, Ewald SJ, White KR, Lloyd ED, Olivier A, Parker PJ: Characterization and differential expression of protein kinase C isoforms in PC12 cells: Differentiation parallels an increase in PKC betaII. FEBS Lett 298: 74–78, 1992

    Google Scholar 

  182. Lin TH, Chu TM: Enhancement of protein kinase C in murine lymphokine-activated killer cells by retinoic acid. J Biol Chem 267: 1335–1339, 1992

    Google Scholar 

  183. Murray NR, Baumgardner GP, Burns DJ, Fields AP: Protein kinase C isotypes in human erythroleukemia (K562) cell proliferation and differentiation. Evidence that βII protein kinase C is required for proliferation. J Biol Chem 268: 15847–15853, 1993

    Google Scholar 

  184. Beckman BS, Mason-Garcia M, Martinez MI, Fermin C: Enhanced expression of the β II subspecies of protein kinase C in differentiating erythroleukemia cells. Exp Cell Res 191: 319–322, 1990

    Google Scholar 

  185. Woloschak GE,Chang-Liu CM, Shearin-Jones P: Regulation of protein kinase C by ionizing radiation. Cancer Research 50: 3963–3967, 1990

    Google Scholar 

  186. Homan EC, Jensen DE, Sando JJ: Protein kinase C isozyme expression in phorbol ester-sensitive and -resistant EL4 thymoma cells. J Biol Chem 266: 5676–5681, 1991

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisions of Hematology/Oncology and Geriatrics, Departments of Medicine and Cell Biology, Duke University Medical Center, Box 3355, 27710, Durham, NC, USA

    Gerard C. Blobe, Lina M. Obeid & Yusuf A. Hannun

Authors
  1. Gerard C. Blobe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lina M. Obeid
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yusuf A. Hannun
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blobe, G.C., Obeid, L.M. & Hannun, Y.A. Regulation of protein kinase C and role in cancer biology. Cancer Metast Rev 13, 411–431 (1994). https://doi.org/10.1007/BF00666107

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00666107

Key words

Search

Navigation